Stay updated on Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a new site version. The change appears to be a backend/software update without altering study content or user actions.
    Difference
    0.1%
    Check dated 2026-07-03T22:36:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision identifier was updated from v3.6.0 to v3.6.2, signaling a new version of the page or its underlying system.
    Difference
    0.1%
    Check dated 2026-06-26T20:53:29.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    New help and join-related sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the recruitment status now shows 'No longer looking for participants'. The 'Intervention/Treatment' label was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T11:37:26.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision label on the page has been updated to v3.5.5, replacing the previous v3.5.4. This indicates a new page version rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-06-05T08:50:26.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4 (replacing v3.5.3), indicating a new version of the page. This appears to be routine maintenance and does not alter study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-05-14T23:14:11.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.2 to v3.5.3, reflecting a minor update to the page's version history.
    Difference
    0.1%
    Check dated 2026-04-30T16:10:47.000Z thumbnail image

Stay in the know with updates to Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib Pembrolizumab Combo in Head & Neck Cancer Clinical Trial page.